Abstrakt

Przypisy

• 1. Bhole M.V., Sadler R., Ramasamy K.: Serum-free light-chain assay: clinical utility and limitations. Ann. Clin. Biochem., 2014; 51: 528-542
  Google Scholar
• 2. Bradwell A.R., Carr-Smith H.D., Mead G.P., Tang L.X., Showell P.J., Drayson M.T., Drew R.: Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin. Chem., 2001; 47: 673-680
  Google Scholar
• 3. Di Noto G., Cimpoies E., Dossi A., Paolini L., Radeghieri A., Caimi L., Ricotta D.: Polyclonal versus monoclonal immunoglobulin-free light chains quantification. Ann. Clin. Biochem., 2015; 52: 327-336
  Google Scholar
• 4. Dispenzieri A., Kyle R., Merlini G., Miguel J.S., Ludwig H., Hajek R., Palumbo A., Jagannath S., Blade J., Lonial S., Dimopoulos M., Comenzo R., Einsele H., Barlogie B., Anderson K., et al.: International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia, 2009; 23: 215-224
  Google Scholar
• 5. Durie B.G. Harousseau J.L., Miguel J.S., Bladé J., Barlogie B., Anderson K., Gertz M., Dimopoulos M., Westin J., Sonneveld P., Ludwig H., Gahrton G., Beksac M., Crowley J., Belch A., et al.: International uniform response criteria for multiple myeloma. Leukemia, 2006; 20: 1467-1473
  Google Scholar
• 6. Dytfeld D., Griffith K.A., Friedman J., Lebovic D., Harvey C., Kaminski M.S., Jakubowiak A.J.: Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial. Leuk. Lymphoma, 2011; 52: 1271-1280
  Google Scholar
• 7. Hoedemakers R.M., Pruijt J.F., Hol S., Teunissen E., Martens H., Stam P., Melsert R., Te Velthuis H.: Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis. Clin. Chem. Lab. Med., 2012; 50: 489-495
  Google Scholar
• 8. Kaplan B., Livneh A., Sela B.A.: Immunoglobulin free light chain dimers in human diseases. Sci. World J., 2011; 11: 726-735
  Google Scholar
• 9. Kapoor P., Kumar S.K., Dispenzieri A., Lacy M.Q., Buadi F., Dingli D., Russell S.J., Hayman S.R., Witzig T.E., Lust J.A., Leung N., Lin Y., Zeldenrust S.R., McCurdy A., Greipp P.R., Kyle R.A., Rajkumar S.V., Gertz M.A.: Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma. J. Clin. Oncol., 2013; 31: 4529-4535
  Google Scholar
• 10. Kim H.S., Kim H.S., Shin K.S., Song W., Kim H.J., Kim H.S., Park M.J.: Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy. Biomed. Res. Int., 2014; 2014: 647238
  Google Scholar
• 11. Krouwer J., Tholen D., Garber C., Goldschmidt H., Kroll M.H., Linnet K., Meier K., Robinowitz M., Kennedy J.W.: CLSI. Method comparison and bias estimation using patient samples; Approved guideline – second edition (interim revision). CLSI document EP09-A2-IR. USA: Clinical Laboratory Standards Institute 2010
  Google Scholar
• 12. Li C., Geng H., Yang Z., Zhong R.: Influence of immunoglobulin light chain dimers on the results of the quantitative nephelometric assay. Clin. Lab., 2011; 57: 53-57
  Google Scholar
• 13. Lock R.J., Saleem R., Roberts E.G., Wallage M.J., Pesce T.J., Rowbottom A., Cooper S.J., McEvoy E.D., Taylor J.L., Basu S.: A multicentre study comparing two methods for serum free light chain analysis. Ann. Clin. Biochem., 2013; 50: 255-261
  Google Scholar
• 14. Martínez-López J.,Paiva B., López-Anglada L., Mateos M.V., Cedena T., Vidríales M.B., Sáez-Gómez M.A., Contreras T., Oriol A., Rapado I., Teruel A.I., Cordón L., Blanchard M.J., Bengoechea E., Palomera L., et al.: Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality. Blood, 2015; 126: 858-862
  Google Scholar
• 15. Pretorius C.J., Klingberg S., Tate J., Wilgen U., Ungerer J.P.: Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots. Ann. Clin. Biochem., 2012; 49: 450-455
  Google Scholar
• 16. Rajkumar S.V., Dimopoulos M.A., Palumbo A., Blade J., Merlini G., Mateos M.V., Kumar S., Hillengass J., Kastritis E., Richardson P., Landgren O., Paiva B., Dispenzieri A., Weiss B., LeLeu X., et al.: International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol., 2014; 15: e538-e548
  Google Scholar
• 17. Rajkumar S.V., Harousseau J.L, Durie B., Anderson K.C., Dimopoulos M., Kyle R., Blade J., Richardson P., Orlowski R., Siegel R., Jagannath S., Facon T., Avet-Loiseau H., Lonial S., Palumbo A., et al.: Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood, 2011; 117: 4691-4695
  Google Scholar
• 18. te Velthuis H., Knop I., Stam P., van den Broek M., Bos H.K., Hol S., Teunissen E., Fischedick K.S., Althaus H., Schmidt B., Wagner C., Melsert R.: N Latex FLC – new monoclonal high-performance assays for the determination of free light chain kappa and lambda. Clin. Chem. Lab. Med., 2011; 49: 1323-1332
  Google Scholar

Pełna treść artykułu